Deependrugs Private Limited

Deependrugs Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials and compliance.
CIN U24304GJ2020PTC113643 Incorporated 23 May 2020 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹17.68 Cr
▼ 30.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹1.3 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Last financials
Mar 2025
Balance sheet date

About Deependrugs Private Limited

Data last updated: 07 January 2026

Deependrugs Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 23 May 2020, the company has been in operation for over 6 years.

Registered with ROC Ahmedabad under CIN U24304GJ2020PTC113643.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sandip Shaileshbhai Shah and Rupen Shaileshkumar Shah.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 314 Siddhi Vinayak Tower – A Survey No. – 212/2 Tps – 84/B B/H.Dcb Office Off S.G. Highway Makarba, Ahmedabad, Gujarat, India – 380051.

As per the financials filed for FY 2025, the company reported a revenue of ₹17.68 Cr, a decline of 30% compared to the previous year.

The company is associated with 1 brand - Deependrugs. As per MCA filings, the company has open charges of ₹1.3 Cr on record.

For more details, the company can be reached via its website deependrugs.in.

Company Details of Deependrugs Private Limited
CIN U24304GJ2020PTC113643
Registration Number 113643
Incorporation Date 23 May 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    A – 314 Siddhi Vinayak Tower – A Survey No. – 212/2 Tps – 84/B B/H.Dcb Office Off S.G. Highway Makarba, Ahmedabad, Gujarat, India – 380051
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Deependrugs Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Deependrugs Private Limited report

Financials, compliance, directors, charges, ownership and filings for Deependrugs Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Deependrugs Private Limited

Deependrugs Private Limited operates one associated brand: DeepenDrugs. These brands represent Deependrugs Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Wholesale trading of APIs, excipients, chemicals, solvents, nutraceuticals. deependrugs.in

Competitors & Alternatives of Deependrugs Private Limited

Brands and companies operating in the same space as Deependrugs Private Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Deependrugs Private Limited

Deependrugs Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Deependrugs Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Deependrugs Private Limited

Deependrugs Private Limited is audited by S N BHAVSAR & CO for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
S N BHAVSAR & CO Locked Locked Locked
Premium access

Complete auditor history for Deependrugs Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Deependrugs Private Limited

Deependrugs Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Sandip Shaileshbhai Shah Director 23 May 2020 6 Years 2 Months Current
Rupen Shaileshkumar Shah Director 23 May 2020 6 Years 2 Months Current

Financials of Deependrugs Private Limited FY 2025 filings available

Deependrugs Private Limited reported revenue of ₹17.68 Cr (down 30.00% YoY) for FY 2025.

Revenue · FY 2025
₹17.68 Cr ▼ 30.00%
Premium access

Ten-year financial statements for Deependrugs Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Deependrugs Private Limited

Premium access

Shareholding and ownership data for Deependrugs Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Deependrugs Private Limited

Open charges
₹1.3 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Others₹1.30 Cr
Latest charge details
DateLenderAmountStatus
02 Mar 2021 Others ₹1.3 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Deependrugs Private Limited

Deependrugs Private Limited has a workforce of 0 employees as of Mar 29, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history for Deependrugs Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Deependrugs Private Limited

Premium access

GST registrations and filing compliance for Deependrugs Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Deependrugs Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Deependrugs Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Deependrugs Private Limited

Premium access

MSME payment history for Deependrugs Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Deependrugs Private Limited

Premium access

Corporate group structure for Deependrugs Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Deependrugs Private Limited

Premium access

MCA filings and documents for Deependrugs Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Deependrugs Private Limited

Activity
30 Sep 2025
Deependrugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Deependrugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
02 Mar 2021
A charge with Others amounted to Rs. 130.00 Lakh with Charge ID 100421231 was registered on 02 Mar 2021.
Charges
02 Mar 2021
A charge with Others of Rs. 130.00 Lakh registered on 02 Mar 2021 with Charge ID 100421231 was modified on 02 Mar 2021.
Directors
23 May 2020
Sandip Shaileshbhai Shah was appointed as a Director on 23 May 2020 & has been associated with this company since 6 years 2 months.
Directors
23 May 2020
Rupen Shaileshkumar Shah was appointed as a Director on 23 May 2020 & has been associated with this company since 6 years 2 months.

Frequently Asked Questions about Deependrugs Private Limited

Deependrugs Private Limited is an active private limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 23 May 2020 (6+ years old) and is registered under CIN U24304GJ2020PTC113643.

Deependrugs Private Limited reported revenue of ₹17.68 Cr for FY 2025 (down 30.00% YoY).

The current directors of Deependrugs Private Limited are:

The primary industry of Deependrugs Private Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.

Deependrugs Private Limited can be reached at the registered office: A – 314 Siddhi Vinayak Tower – A Survey No. – 2122 Tps – 84B BH.Dcb Office Off S.G. Highway Makarba, Ahmedabad, Gujarat, India – 380051, or through the website deependrugs.in.

The authorised capital is ₹10 Lakh, and the paid-up capital is ₹10 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available